Literature DB >> 15694115

Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate.

P Sytze van Dam1, Channa F de Winter, Rehana de Vries, Jeroen van der Grond, Madeleine L Drent, Marijn Lijffijt, J Leon Kenemans, André Aleman, Edward H F de Haan, Hans P F Koppeschaar.   

Abstract

Cognitive deficits have been reported in adults with childhood-onset growth hormone (GH) deficiency. We evaluated cognitive deficits simultaneously with parameters for neuronal integrity using (1)H magnetic resonance spectroscopy (MRS) in a cross-sectional design. We studied 11 adults (mean age 24.5 years) with childhood-onset GH deficiency, which persisted after reaching final height. All subjects were evaluated after interruption of GH supplementation for at least 3 months. We performed neuropsychological assessment (NPA) using tests evaluating memory, mental processing speed, reading ability and executive functioning. MRS was used to assess brain N-acetylaspartate (NAA)/choline ratios. Data were compared with an age-, sex- and education-matched control group (n=9, mean age 27.3 years). NPA demonstrated attenuated performance of the patients in the delayed verbal memory recall score (P<0.05) and the trail making A test (P<0.05), a measure of planning of behavior, processing speed and attention. Other neuropsychological tests were not affected. NAA/choline ratios were significantly reduced (P<0.01) in GH deficient subjects. Specific cognitive defects indicating affected memory and attention were found in patients with childhood-onset GH deficiency. These defects occur simultaneously with reduced neuronal integrity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694115     DOI: 10.1016/j.psyneuen.2004.10.002

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  14 in total

1.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

2.  IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan.

Authors:  Nicole M Ashpole; Sreemathi Logan; Andriy Yabluchanskiy; Matthew C Mitschelen; Han Yan; Julie A Farley; Erik L Hodges; Zoltan Ungvari; Anna Csiszar; Sixia Chen; Constantin Georgescu; Gene B Hubbard; Yuji Ikeno; William E Sonntag
Journal:  Geroscience       Date:  2017-04-13       Impact factor: 7.713

3.  High Postnatal Growth Hormone Levels Are Related to Cognitive Deficits in a Group of Children Born Very Preterm.

Authors:  Shannon E Scratch; Peter J Anderson; Lex W Doyle; Deanne K Thompson; Zohra M Ahmadzai; Ronda F Greaves; Terrie E Inder; Rodney W Hunt
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

Review 4.  The enigmatic role of growth hormone in age-related diseases, cognition, and longevity.

Authors:  Gabriela Colon; Tatiana Saccon; Augusto Schneider; Marcelo B Cavalcante; Derek M Huffman; Darlene Berryman; Ed List; Yuji Ikeno; Nicolas Musi; Andrzej Bartke; John Kopchick; James L Kirkland; Tamara Tchkonia; Michal M Masternak
Journal:  Geroscience       Date:  2019-09-04       Impact factor: 7.713

5.  Effect of growth hormone replacement therapy on cognition after traumatic brain injury.

Authors:  Walter M High; Maria Briones-Galang; Jessica A Clark; Charles Gilkison; Kurt A Mossberg; Dennis J Zgaljardic; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2010-09       Impact factor: 5.269

6.  Genetic and environmental contributions to the association between anthropometric measures and iq: a study of Minnesota twins at age 11 and 17.

Authors:  Karri Silventoinen; William G Iacono; Robert Krueger; Matthew McGue
Journal:  Behav Genet       Date:  2011-12-04       Impact factor: 2.805

Review 7.  Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Authors:  Ferenc Deak; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

8.  Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.

Authors:  Seth D Friedman; Laura D Baker; Soo Borson; J Eric Jensen; Suzanne M Barsness; Suzanne Craft; George R Merriam; Randolph K Otto; Edward J Novotny; Michael V Vitiello
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

9.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

10.  Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation.

Authors:  E Nieves-Martinez; W E Sonntag; A Wilson; A Donahue; D P Molina; J Brunso-Bechtold; M M Nicolle
Journal:  J Endocrinol       Date:  2009-10-08       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.